Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Vitamin D: A new anti-infective agent?
Elisabetta Borella
, Gideon Nesher
, Eitan Israeli
,
Yehuda Shoenfeld
*
*
Corresponding author for this work
University of Padua
Sheba Medical Center at Tel Hashomer
Shaare Zedek Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
73
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vitamin D: A new anti-infective agent?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cathelicidin
100%
Vitamin D
100%
1,25-dihydroxyvitamin D3
100%
Anti-infective Agents
100%
Pneumonia
66%
Sun Exposure
66%
Increased Incidence
33%
Polypeptide
33%
Protective Effect
33%
Epithelial Cells
33%
Adjuvant Therapy
33%
Antibiotics
33%
Phagocytes
33%
Macrophages
33%
Sepsis
33%
HIV Infection
33%
Urinary Tract Infection
33%
Polymorphonuclear Leukocytes
33%
Influenza
33%
Otitis Media
33%
Lysosome
33%
Hepatitis C Virus Infection
33%
Hepatitis B
33%
Enteric Infections
33%
Antibiotic Agents
33%
Innate Immune Defense
33%
B Hepatitis
33%
Upper Respiratory Tract Infection
33%
Tuberculosis Patients
33%
Tuberculosis Treatment
33%
Defensin
33%
Common Cold
33%
Mycobacterium Infections
33%
Sanatorium
33%
Dengue Hepatitis
33%
Vaginosis
33%
Clostridium Infections
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cathelicidin
100%
Vitamin D
100%
Calcitriol
100%
Antimicrobial Agent
100%
Infection
66%
Polypeptide
33%
Infectious Agent
33%
Antibiotic Agent
33%
Sepsis
33%
Hepatitis C
33%
Urinary Tract Infection
33%
Otitis Media
33%
Hepatitis B
33%
Dengue
33%
Intestine Infection
33%
Human Immunodeficiency Virus Infection
33%
Upper Respiratory Tract Infection
33%
Sun Exposure
33%
Common Cold
33%
Clostridium Infection
33%
Mycobacteriosis
33%